Literature DB >> 11563213

Physicians Taking Action Against Smoking: an intervention program to optimize smoking cessation counselling by Montreal general practitioners.

M Tremblay1, A Gervais, C Lacroix, J O'Loughlin, H Makni, G Paradis.   

Abstract

In 1997 the Direction de la santé publique de Montréal-Centre initiated "Physicians Taking Action Against Smoking," a 5-year intervention program to improve the smoking cessation counselling practices of general practitioners (GPs) in Montreal. Program development was guided by the precede-proceed model. This model advocates identifying factors influencing the outcome, in this case counselling practices. These factors are then used to determine the program objectives, to develop and tailor program activities and to design the evaluation. Program activities during the first 3 years included cessation counselling workshops and conferences for GPs, publication of articles in professional interest journals, publication of clinical guidelines for smoking cessation counselling and dissemination of educational material for both GPs and smokers. The program also supported activities encouraging smokers to ask their GPs to help them stop smoking. Results from 2 cross-sectional surveys, conducted in 1998 and 2000, of random samples of approximately 300 GPs suggest some improvements over time in several counselling practices, including offering counselling to more patients and discussing setting a quit date. More improvements were observed among female than male GPs in both psychosocial factors related to counselling and specific counselling practices. For example, improvements were noted among female GPs in self-perceived ability to provide effective counselling and in the belief that it is important to schedule specific appointments to help patients quit; in addition, the perceived importance of several barriers to counselling decreased among female GPs. A greater proportion of the female respondents to the 2000 survey offered written educational material than was the case in 1998, and a greater proportion of the male GPs devoted more time to counselling in 2000 than in 1998; however, among male GPs the proportion who discussed the pros and cons of smoking with patients in the pre-contemplation stage declined between 1998 and 2000, as did the proportion who referred patients in the preparation stage to community resources. Our experience suggests that an integrated, theory-based program to improve physicians' counselling practices could be a key component of a comprehensive strategy to reduce tobacco use.

Entities:  

Mesh:

Year:  2001        PMID: 11563213      PMCID: PMC81419     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  13 in total

1.  Smoking cessation counseling practices of general practitioners in Montreal.

Authors:  J O'Loughlin; H Makni; M Tremblay; C Lacroix; A Gervais; V Déry; G Meshefedjian; G Paradis
Journal:  Prev Med       Date:  2001-12       Impact factor: 4.018

Review 2.  Implementing preventive care in clinical practice. II. Problems for managers, clinicians and patients.

Authors:  W B Carter; D W Belcher; T S Inui
Journal:  Med Care Rev       Date:  1981

3.  Right to bill may affect amount of tobacco counselling by MDs.

Authors:  P Sullivan; A Kothari
Journal:  CMAJ       Date:  1997-01-15       Impact factor: 8.262

4.  Do female primary care physicians practise preventive care differently from their male colleagues?

Authors:  C A Woodward; B G Hutchison; J Abelson; G Norman
Journal:  Can Fam Physician       Date:  1996-12       Impact factor: 3.275

Review 5.  The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline.

Authors: 
Journal:  JAMA       Date:  1996-04-24       Impact factor: 56.272

6.  Mobilizing physicians to conduct clinical intervention in tobacco use through a medical-association program: 5 years' experience in British Columbia.

Authors:  F Bass
Journal:  CMAJ       Date:  1996-01-15       Impact factor: 8.262

Review 7.  A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives.

Authors: 
Journal:  JAMA       Date:  2000-06-28       Impact factor: 56.272

8.  Preventive care and barriers to effective prevention. How do family physicians see it?

Authors:  B G Hutchison; J Abelson; C A Woodward; G Norman
Journal:  Can Fam Physician       Date:  1996-09       Impact factor: 3.275

9.  Reminders to physicians from an introspective computer medical record. A two-year randomized trial.

Authors:  C J McDonald; S L Hui; D M Smith; W M Tierney; S J Cohen; M Weinberger; G P McCabe
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

10.  No magic bullets: a systematic review of 102 trials of interventions to improve professional practice.

Authors:  A D Oxman; M A Thomson; D A Davis; R B Haynes
Journal:  CMAJ       Date:  1995-11-15       Impact factor: 8.262

View more
  4 in total

1.  Does the Presence of a Smoking Cessation Clinical Trial Affect Staff Practices Related to Smoking?

Authors:  Jongserl Chun; Joseph R Guydish; Kevin Delucchi
Journal:  J Drug Issues       Date:  2009-04-01

2.  Developing cessation interventions for the social and community service setting: a qualitative study of barriers to quitting among disadvantaged Australian smokers.

Authors:  Jamie Bryant; Billie Bonevski; Christine Paul; Jon O'Brien; Wendy Oakes
Journal:  BMC Public Health       Date:  2011-06-24       Impact factor: 3.295

3.  [Prevalence and factors associated with clinical counselling on drug use among internal specialists residents of Andalusia (Spain)].

Authors:  María de la Villa Juárez-Jiménez; Alejandro Pérez-Milena; Francisco Javier Valverde-Bolívar; Carmen Rosa-Garrido
Journal:  Aten Primaria       Date:  2015-02-20       Impact factor: 1.137

4.  Avoiding the danger that stop smoking services may exacerbate health inequalities: building equity into performance assessment.

Authors:  Allan Low; Louise Unsworth; Anne Low; Iain Miller
Journal:  BMC Public Health       Date:  2007-08-09       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.